Stay updated on TITAN-TCC Nivolumab Tailored Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the TITAN-TCC Nivolumab Tailored Immunotherapy Clinical Trial page.

Latest updates to the TITAN-TCC Nivolumab Tailored Immunotherapy Clinical Trial page
- ChecktodayChange DetectedA publication citation in Publications (JAMA Oncol. 2024) was added and the same citation was removed, resulting in no net change to the page's content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe Locations section now includes Thuringia as a study site, and the HHS Vulnerability Disclosure link and the Thuringia Locations entry have been removed.SummaryDifference0.2%

- Check22 days agoNo Change Detected
- Check44 days agoChange DetectedPublications section wording updated to clarify auto-population from PubMed; Revision: v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check51 days agoChange DetectedRemoved the general funding-status banner that previously appeared on the page. The core study details and content remain unchanged.SummaryDifference0.3%

- Check65 days agoChange DetectedNo significant content changes detected on the TITAN-TCC study details page (NCT03219775); the page structure and core information appear unchanged.SummaryDifference0.3%

- Check93 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference2%

Stay in the know with updates to TITAN-TCC Nivolumab Tailored Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TITAN-TCC Nivolumab Tailored Immunotherapy Clinical Trial page.